Effect of Preemptive Therapy vs Antiviral Prophylaxis on Cytomegalovirus Disease in Seronegative Liver Transplant Recipients With Seropositive Donors: A Randomized Clinical Trial

IMPORTANCE: Despite the use of a cytomegalovirus (CMV) prevention strategy of antiviral prophylaxis for high-risk CMV-seronegative liver transplant recipients with seropositive donors, high rates of delayed-onset postprophylaxis CMV disease occur. An alternate approach, preemptive therapy (initiatio...

Descripció completa

Guardat en:
Dades bibliogràfiques
Publicat a:JAMA
Autors principals: Singh, Nina, Winston, Drew J., Razonable, Raymund R., Lyon, G. Marshall, Silveira, Fernanda P., Wagener, Marilyn M., Stevens-Ayers, Terry, Edmison, Bradley, Boeckh, Michael, Limaye, Ajit P.
Format: Artigo
Idioma:Inglês
Publicat: American Medical Association 2020
Matèries:
Original Investigation
Accés en línia:https://ncbi.nlm.nih.gov/pmc/articles/PMC7157180/
https://ncbi.nlm.nih.gov/pubmed/32286644
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1001/jama.2020.3138
Etiquetes: Afegir etiqueta
Sense etiquetes, Sigues el primer a etiquetar aquest registre!

Ítems similars